Suppr超能文献

氟-18-氟代脱氧葡萄糖正电子发射断层扫描成像在子宫肉瘤中的诊断性能:文献的系统评价和荟萃分析。

Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.

机构信息

*Nuclear Medicine Research Center, †Women's Health Research Center, Mashhad University of Medical Sciences; ‡Faculty of Medicine, Ghaem Hospital, Mashhad, Iran; and §Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

出版信息

Int J Gynecol Cancer. 2013 Oct;23(8):1349-56. doi: 10.1097/IGC.0b013e3182a20e18.

Abstract

OBJECTIVE

We reviewed the medical literature on the application of fluorine-18-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) imaging in the management of uterine sarcomas and presented the results in systematic review and meta-analysis format.

METHODS

Medline, SCOPUS, and ISI Web of Knowledge were searched electronically with "PET AND (Uterine OR Uterus)" as key words. All studies evaluating the accuracy of (18)F-FDG imaging in the staging or restaging of uterine sarcomas were included if enough data could be extracted for calculation of sensitivity and/or specificity.

RESULTS

Eight studies were included in the systematic review. Only 2 studies reported the accuracy of (18)F-FDG PET imaging in the primary staging of uterine sarcoma with low sensitivity for lymph node staging. For restaging (detection of recurrence), all 8 included studies had quantitative data, and the patient-based pooled sensitivity and specificity were 92.1% (95% confidence interval [95% CI], 82.4-97.4) and 96.2% (95% CI, 87-99.5), respectively. On a lesion-based analysis, sensitivity was 86.3% (95% CI, 76.7-92.9), and specificity was 94.4% (95% CI, 72.7-99.9). Device used (PET vs PET/CT), spectrum of studied patients, and histology of the sarcoma seem to be factors influencing the overall accuracy of (18)F-FDG PET imaging.

CONCLUSIONS

(8)Fluorine-18-fluorodeoxyglucose PET and PET/CT seem to be accurate methods for detection and localization of recurrence in patients with uterine sarcoma. Further large multicenter studies are needed to validate our results and to correlate both sarcoma type and spectrum of patients to the diagnostic performance of (18)F-FDG PET imaging in recurrence detection. The studies evaluating the accuracy of (18)F-FDG PET imaging for the primary staging of uterine sarcoma are very limited, and no definite conclusion can be made in this regard.

摘要

目的

我们回顾了氟-18-氟代脱氧葡萄糖正电子发射断层扫描((18)F-FDG PET)成像在子宫肉瘤管理中的应用的医学文献,并以系统评价和荟萃分析的形式呈现了结果。

方法

通过关键词“PET AND (Uterine OR Uterus)”,在 Medline、SCOPUS 和 ISI Web of Knowledge 上进行电子检索。如果可以提取足够的数据来计算敏感性和/或特异性,则纳入评估(18)F-FDG 成像在子宫肉瘤分期或重新分期中的准确性的所有研究。

结果

系统评价纳入了 8 项研究。只有 2 项研究报道了(18)F-FDG PET 成像在子宫肉瘤原发分期中的准确性,其淋巴结分期的敏感性较低。对于重新分期(检测复发),所有 8 项纳入的研究均具有定量数据,基于患者的汇总敏感性和特异性分别为 92.1%(95%置信区间[95%CI],82.4-97.4)和 96.2%(95%CI,87-99.5)。基于病变的分析,敏感性为 86.3%(95%CI,76.7-92.9),特异性为 94.4%(95%CI,72.7-99.9)。所使用的设备(PET 与 PET/CT)、研究患者的范围以及肉瘤的组织学似乎是影响(18)F-FDG PET 成像总体准确性的因素。

结论

(18)氟-18-氟代脱氧葡萄糖 PET 和 PET/CT 似乎是检测和定位子宫肉瘤患者复发的准确方法。需要进一步的大型多中心研究来验证我们的结果,并将肉瘤类型和患者范围与(18)F-FDG PET 成像在复发检测中的诊断性能相关联。评估(18)F-FDG PET 成像在子宫肉瘤原发分期中的准确性的研究非常有限,因此在这方面无法得出明确的结论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验